JSM 2017 Online Program

Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme

Keyword Search Criteria: Maximum tolerated dose returned 5 record(s)

Sunday, 07/30/2017

Basket Trial Considerations in Phase Ib/IIa Oncology Studies of Targeted Therapy
Yihua Zhao, Boehringer Ingelheim Pharmaceuticals, Inc.
4:45 PM

Monday, 07/31/2017

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades
Sungjin Kim, Cedars-Sinai Medical Center; Marcio Diniz, Cedars Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center

Drug Combination Dose Allocation Using Minimal Sets and Coherence in Partially Ordered Sets in Phase I Cancer Trials
Galen Cook-Wiens, Cedars Sinai Medical Center; Matthieu Clertant, Cedars-Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center

A Latent Variable Approach to Elicit Continuous Toxicity Scores and Severity Weights for Multiple Toxicities in Dose-Finding Oncology Trials
Nathaniel O'Connell, Medical University of South Carolina; Elizabeth Garrett-Mayer, Medical University of South Carolina
2:05 PM

Thursday, 08/03/2017

A Robust Paradigm of Finding the Maximum Tolerated Dose in Phase I Cancer Clinical Trials
Tina Young, Bristol-Myers Squibb; Dirk Moore, Rutgers School of Public Health; Yong Lin, Rutgers; Weichung Joe Shih, Rutgers School of Public Health
10:50 AM